Cue Biopharma, Inc.
CUE
$29.47
$0.210.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 38.25% | -26.98% | 99.05% | -39.94% | -27.86% |
| Total Receivables | 225.68% | 329.70% | -- | -- | -70.02% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -57.96% | 32.51% | 24.80% | 133.91% | -52.20% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 43.24% | -16.29% | 93.61% | -36.63% | -32.53% |
|
|
|||||
| Total Current Assets | 43.24% | -16.29% | 93.61% | -36.63% | -32.53% |
| Net Property, Plant & Equipment | -12.10% | -11.90% | 35.51% | -15.06% | 5.15% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.22% | -78.65% | 94.08% | -0.05% | -25.02% |
| Total Assets | 33.40% | -22.26% | 82.92% | -30.87% | -28.16% |
|
|
|||||
| Total Accounts Payable | 68.14% | -35.26% | -4.15% | 34.04% | -56.39% |
| Total Accrued Expenses | -13.90% | 23.25% | -64.11% | 45.46% | -9.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -45.23% | -22.98% | -34.81% | -11.74% | 14.80% |
| Total Finance Division Other Current Liabilities | -22.93% | -18.40% | 1,690.47% | 529.41% | -67.18% |
| Total Other Current Liabilities | -22.93% | -18.40% | 1,690.47% | 529.41% | -67.18% |
| Total Current Liabilities | -13.08% | -19.37% | 24.24% | 13.21% | -18.47% |
|
|
|||||
| Total Current Liabilities | -13.08% | -19.37% | 24.24% | 13.21% | -18.47% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.83% | -13.53% | 1,663.64% | -82.45% | -24.36% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 0.00% | -- | -- | -- |
| Total Liabilities | -14.23% | -18.41% | 43.86% | 6.68% | -24.44% |
|
|
|||||
| Common Stock & APIC | 3.03% | 0.67% | 5.56% | 0.37% | 0.46% |
| Retained Earnings | 0.43% | -2.05% | -2.40% | -3.59% | -2.86% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 99.55% | -27.06% | 175.97% | -62.40% | -31.01% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 99.55% | -27.06% | 175.97% | -62.40% | -31.01% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 99.55% | -27.06% | 175.97% | -62.40% | -31.01% |
|
|
|||||